OTC
CELG

Opera Trading Capital’s Celgene Corp CELG Stock Holding History

Opera Trading Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,761
Closed -$426K – 196
2018
Q3 		$426K Buy
+4,761
New +$421K 0.08% 87
2016
Q3 		– Sell
-667
Closed -$66K – 150
2016
Q2 		$66K Sell
667
-896
-57% -$92.7K 0.01% 102
2016
Q1 		$156K Buy
1,563
+900
+136% +$92.7K 0.04% 100
2015
Q4 		$79K Buy
+663
New +$76.7K 0.02% 83

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Opera Trading Capital's CELG Position: Q4 2018 in Review

Opera Trading Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 4,761 shares — an estimated $426K sold.

Opera Trading Capital first reported a position in CELG in Q4 2015 and held it in 4 quarters. The position peaked at $426K in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Opera Trading Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Opera Trading Capital sold 4,761 Celgene Corp shares in Q4 2018, an estimated $426K.
  • Opera Trading Capital first reported a position in Celgene Corp in Q4 2015 and held it in 4 quarters.
  • Opera Trading Capital's Celgene Corp position peaked at $426K in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Opera Trading Capital's 13F filing for Q4 2018, filed 22 Jan 2019.